Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparing fenugreek tablet and mefenamic acid in primary dysmenorrhea
IRCT20260629070010N1Phase 3Recruiting
- Sponsor
- Shahrekord University of Medical Sciences
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of trigonella foenum-graecum and Mefenamic acid in primary dysmenorrhea (PD) (2 arms), sponsored by Shahrekord University of Medical Sciences. Started Jan 2026; status: recruiting.
02
Drugs
trigonella foenum-graecumMefenamic acid
03
Conditions
primary dysmenorrhea (PD)
Beyond the preview
Go deeper on IRCT20260629070010N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260629070010N1.